SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-018992
Filing Date
2020-04-28
Accepted
2020-04-28 08:01:15
Documents
50
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q odt-10q_20200331.htm 10-Q 780445
2 EX-31.1 odt-ex311_7.htm EX-31.1 18261
3 EX-31.2 odt-ex312_6.htm EX-31.2 18343
4 EX-32.1 odt-ex321_8.htm EX-32.1 15074
5 GRAPHIC gtqprvckjnau000001.jpg GRAPHIC 28085
  Complete submission text file 0001564590-20-018992.txt   2827119

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT odt-20200331.xml EX-101.INS 457639
7 XBRL TAXONOMY EXTENSION SCHEMA odt-20200331.xsd EX-101.SCH 28714
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20200331_cal.xml EX-101.CAL 28038
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20200331_def.xml EX-101.DEF 47762
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20200331_lab.xml EX-101.LAB 228239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20200331_pre.xml EX-101.PRE 157318
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 20822377
SIC: 2834 Pharmaceutical Preparations